RxDoctor Payments Data

Justine Ade, MD

Allergy & Immunology · Urbana, ILNPI 1457707010

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.5% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Biocryst US Sales Co., LLC at 25.6% of the total. 2025 is the largest year on record at $212, 2.0 times the $105 reported in 2022. That places this record below the midpoint for allergy & immunology clinicians in IL, where the typical reported total is $2,761.

$546in general payments, 2019–2025

Across 27 payments — averaging $20.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biocryst US Sales Co., LLC$140
  • Regeneron Healthcare Solutions, Inc.$93
  • ARS Pharmaceuticals Operations, Inc.$75
  • AstraZeneca$50
  • Greer Laboratories, Inc.$45
  • Kaleo, Inc.$43
  • plus $99 from 4 others

What the payments were for

  • Food & beverage$50592%
  • Education$418%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$546 in reported general payments places this provider in the 20th percentile of 161 allergy & immunology providers in Illinois.

See all allergy & immunology providers in Illinois →

Medicare billing

Part B allowed, 2024
$8,095
Medicare patients
51
Services billed
509

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XolairOmalizumab13$35,959
Epinephrine15$3,023
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate13$2,575
Azelastine Hcl44$1,289
Albuterol Sulfate HfaAlbuterol Sulfate15$713
Fluticasone Propionate23$398
Montelukast Sodium19$146

Paid to pharmacies, not to this prescriber.

Other allergy & immunology in Urbana

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →